Rosse W F
J Clin Invest. 1969 Nov;47(11):2430-45. doi: 10.1172/JCI105926.
The fixation of the first component of complement (C'1a) by human antibodies and human cells has been studied by the use of the C'1a fixation and transfer test (C'1a FT test) of Borsos and Rapp.Cold agglutinin antibodies appear to require no more than one antibody molecule to fix one molecule of C'1a. Most warm agglutinin antibodies are IgG in immunoglobulin type and require at least two molecules of antibody to fix a molecule of C'1a. Donath-Landsteiner antibody has the same requirements for C'1a fixation. A single example of a warm agglutinin antibody which appears to require one molecule of antibody for the fixation of C'1a was found. Antibodies of the Rh system do not fix significant amounts of C'1a in the absence of anti-antibody when antiserum of a single Rh specificity was used. However, when three antisera at different specificity are present, C'1a may be fixed. Under these conditions cells from a patient with paroxysmal nocturnal hemoglobinuria may be lysed when fresh serum is added to provide the other components of complement. The presence of IgG antibodies could be detected by the use of anti-IgG(Hu) antiserum and a one-to-one relationship between the concentration of antiserum in the reaction and the amount of C'1a fixed could be established. The effect of temperature, ionic strength, papainization of the red cells, and repeated washing of the red cell-antibody aggregates on the amount of C'1a fixed was investigated. Conditions of maximal C'1a fixation were established for each class of antibodies. Globulins present in normal isologous or autologous serum are absorbed in small amounts to normal red cells in a manner analogous to warm agglutinin antibody. Their presence is detectable by the C'1a fixation and transfer test only with antiglobulin antiserum. Within certain limits, the C'1a fixation and transfer test provides a quantitative measure of the reaction of human red cells and antibodies to antigens on their surface.
运用博尔索斯和拉普的补体第一成分(C'1a)固定及转移试验(C'1a FT试验),对人抗体和人细胞固定补体第一成分(C'1a)的情况进行了研究。冷凝集素抗体似乎只需一个抗体分子就能固定一个C'1a分子。大多数温凝集素抗体在免疫球蛋白类型上属于IgG,需要至少两个抗体分子才能固定一个C'1a分子。多纳-兰德斯泰纳抗体对C'1a固定有相同的要求。发现了一个温凝集素抗体的例子,它似乎只需一个抗体分子就能固定C'1a。当使用单一Rh特异性的抗血清时,在没有抗抗体的情况下,Rh系统的抗体不会固定大量的C'1a。然而,当存在三种不同特异性的抗血清时,C'1a可能会被固定。在这些条件下,当加入新鲜血清以提供补体的其他成分时,阵发性夜间血红蛋白尿患者的细胞可能会被裂解。通过使用抗IgG(Hu)抗血清可以检测到IgG抗体的存在,并且可以确定反应中抗血清浓度与固定的C'1a量之间的一对一关系。研究了温度、离子强度、红细胞的木瓜蛋白酶处理以及红细胞-抗体聚集体的反复洗涤对固定的C'1a量的影响。为每类抗体确定了最大C'1a固定的条件。正常同种或自体血清中存在的球蛋白会以类似于温凝集素抗体的方式少量吸附到正常红细胞上。只有使用抗球蛋白抗血清,通过C'1a固定及转移试验才能检测到它们的存在。在一定限度内,C'1a固定及转移试验为人类红细胞和抗体与其表面抗原的反应提供了一种定量测量方法。